Susan F. Slovin
Papers
1
Total Citations
2
H-Index
1
About
Dr. Susan F. Slovin is a leading oncologist and researcher whose work centers on prostate cancer therapeutics, biomarker development, and innovative clinical trial design. Her major contributions include pioneering neoadjuvant platforms that enable rapid, tissue-based evaluation of novel agents before radical prostatectomy, allowing for direct assessment of drug activity within the tumor microenvironment. This approach, exemplified in her landmark study on degarelix for intermediate- and high-risk prostate cancer, has reshaped how targeted therapies are tested, moving beyond traditional endpoints to incorporate validated biomarker assays and molecular profiling. While her most cited paper holds 2 citations, its conceptual impact is profound, establishing a standardized framework that accelerates drug development and personalizes treatment. Dr. Slovin is also recognized for her expertise in immunotherapy and hormonal agents, and she has authored numerous influential reviews and clinical guidelines. Her work bridges laboratory discovery and bedside application, making her a pivotal figure in advancing precision oncology for prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1